💼 Kiwoom Securities: Checking the PF and Debt Risks Hidden Behind AI Innovation - 2026.06.13
Kiwoom Securities Co., Ltd.

Peanut

June 13, 2026

💼 Kiwoom Securities: Checking the PF and Debt Risks Hidden Behind AI Innovation - 2026.06.13

Hey, it's Peanut, weighing the fundamentals. I wonder if everyone's accounts are safe in the recent rollercoaster market. On the 12th, Kiwoom Securities' stock closed at 363,500 KRW, showing a 6.44% increase. But we must always look at the shadows behind a bull market. Let's take some time to evaluate if this stock price increase is truly justified and verifiable with numbers.

💼 AI Wealth Management 'KiwooMe' and Fundamentals, Are They Really Solid?

There have been notable movements in the retail sector recently. In March, Kiwoom Securities launched the open beta of 'KiwooMe', a generative AI-based wealth management chatbot, upgrading its services [3]. It's reported that the MTS community service users also surpassed 1.5 million in just about 4 months since its launch [3]. On top of this, by being selected as the underwriter for the KOSDAQ listing of the vascular medical device company 'Enventric', they are steadily building their IB pipeline [5].

Perhaps due to this physical strength in their core business, Shinhan Securities picked Kiwoom Securities as the top preferred stock in the securities sector [4]. With the cumulative daily average trading volume for Q2 2026 expanding to 110 trillion KRW, the analysis suggests there is room for stock revaluation, considering the valuation where the Price-to-Book Ratio (PBR) hovers around 1x despite an earnings capacity approaching a Return on Equity (ROE) of 20% [4]. Looking at the PBR 1.0 level numbers, one could think that downward rigidity is secured to some extent.

⚠️ JTBC Debt Default and PF Risks, Possibility of a Value Trap

However, we need to be cautious rather than getting drunk on the bullish atmosphere. We must point out the potential insolvency risk factors that have recently surfaced.

First is the issue of JTBC's failure to repay 20.6 billion KRW in securitized borrowings. It's known that Kiwoom Securities invested 15 billion KRW here, putting the recovery of principal and interest at maturity on high alert [1]. It might look small as a single case, but it's not a light issue in terms of credit risk management.

Warning lights have also turned on in the Busan Osiria Meditown PF project. Regarding this project, which is suffering from financial difficulties due to unsold units, a Special Purpose Company (SPC) established by Kiwoom Securities provided refinancing funds by issuing 80 billion KRW worth of Asset-Backed Short-Term Bonds (ABSTB) [2]. Considering that the developer is in a state of complete capital impairment, there is a risk that this exposure could transfer into bad debt expenses in the future.

🛑 Short-Term Swing Perspective and Contemplating Profit-Taking Trims

Peanut sees that we must meticulously monitor potential insolvency risks in the current stock price rebound phase.

The favorable news of AI innovation and increased trading volume might support the current multiple, but the aforementioned risk exposures of 15 billion and 80 billion KRW units harbor the possibility of a value trap that could drag down quarterly earnings at any time. It would be rational to approach this from a short to mid-term swing perspective, but whenever additional news regarding PF and corporate finance exposure comes out, put it on the candidate list for profit-taking trims for risk management and respond carefully. Let's not forget that a temporary adjustment phase to cool down market overheating could arrive [6].


📰 Reference News (6)

1

JTBC, Credit Rating

네이버뉴스 · 2026.06.12

📰 View original
2

Osiria Meditown PF Maturity Extended, Hanwha Receivables Hit 138.8B Won

네이버뉴스 · 2026.06.13

📰 View original
3

'Brokerage AI' Becomes Your PB... Excels at Investment Advice and Wealth Management [AI Rewrites the Company]④

네이버뉴스 · 2026.06.13

📰 View original
4

Securities Stocks: Slower Than the Index, Faster Than Earnings [Best Analyst Top Picks]

네이버뉴스 · 2026.06.13

📰 View original
5

[VC’s Pick] Domestic Vascular Medical Device 'Enventrick' Secures Pre-IPO Funding

네이버뉴스 · 2026.06.13

📰 View original
6

Jensen Huang Says "Buy Chip Stocks," But Brokerages Say...

네이버뉴스 · 2026.06.13

📰 View original

Comments 0

to comment Login